Fresenius Medical Care AG FMS
Set alert
22.60 USD +0.13 +0.58%
As of Nov 2, 3:34 PM ET
22.36 Day range 22.72
20.02 52-week range 26.66
- YTD
- -5.12%
- 1 year
- -15.80%
- Open
- 22.70
- Prev close
- 22.47
- Mkt cap
- 12.03B
- Vol
- 1.11M
- Avg vol
- 930.96K
- EPS
- 1.94
- P/E
- 11.65
- Div yield
- 2.62%
More statistics
- Low
- 22.36
- High
- 22.72
- Forward P/E
- 7.55
- Beta
- 0.81
- Short ratio
- 4.08
- Inst. own
- 9.96%
- Dividend
- 0.87
- Ex-div date
- May 21, 2026
- Earnings
- Nov 3, 2026
- 50-d avg
- 22.41
- 200-d avg
- 22.87
- 1y target
- 23.77
3M chart
Events in this range
- Aug 3, 2026Earnings: 0.66; estimate 0.616; surprise 7.14%
- Aug 6, 2026Rating: Bernstein · Market Perform → Market Perform
- Oct 12, 2026Rating: Truist Securities · Hold → Hold
Signals (17)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 7, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 18, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| RSI: Oversold | Sep 10, 2026 | 1 month ago |
| RSI: Oversold | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 3 months ago |
| MACD: Sell Signal | Aug 4, 2026 | 3 months ago |
Financial health
Altman Z-Score
1.74 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
8 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 5
- Return on Equity 3
- Return on Assets 3
- Debt / Equity 1
- P/E 3
- P/B 5
Valuation
P/E 12.1×
FY 2016 5y median 23.9× FY 2025
P/S 0.6×
FY 2016 5y median 0.7× FY 2025
P/B 0.8×
FY 2016 5y median 0.9× FY 2025
P/FCF 7.0×
FY 2016 5y median 7.6× FY 2025
EV/EBITDA 6.2×
FY 2016 5y median 7.1× FY 2025
EV/Sales 1.1×
FY 2016 5y median 1.2× FY 2025
FCF Yield 14.4%
FY 2016 5y median 13.1% FY 2025
Profitability
Gross Margin 25.6%
FY 2016 5y median 25.3% FY 2025
Operating Margin 9.3%
FY 2016 5y median 7.8% FY 2025
Net Margin 5.0%
FY 2016 5y median 3.5% FY 2025
ROE 6.8%
FY 2016 5y median 4.8% FY 2025
ROIC 5.3%
FY 2016 5y median 3.5% FY 2025
ROA 3.2%
FY 2016 5y median 1.9% FY 2025
Growth (YoY)
Revenue 1.5%
FY 2016 FY 2025
Operating Income 24.5%
FY 2016 FY 2025
EPS (diluted) 83.6%
FY 2016 FY 2025
Free Cash Flow 0.5%
FY 2016 FY 2025
Financial Health
Current Ratio 1.3×
FY 2016 5y median 1.3× FY 2025
Quick Ratio 0.9×
FY 2016 5y median 0.9× FY 2025
Debt / Equity 0.8×
FY 2016 5y median 0.9× FY 2025
Net Debt / EBITDA 2.7×
FY 2016 5y median 3.3× FY 2025
Interest Coverage 4.8×
FY 2016 5y median 4.2× FY 2025
Dividends
Dividend Yield 3.4%
FY 2016 5y median 2.7% FY 2025
Payout Ratio 41.5%
FY 2016 5y median 58.7% FY 2025
Annual · latest fiscal year ends 2025-12-31